JP2016521277A5 - - Google Patents

Download PDF

Info

Publication number
JP2016521277A5
JP2016521277A5 JP2016511017A JP2016511017A JP2016521277A5 JP 2016521277 A5 JP2016521277 A5 JP 2016521277A5 JP 2016511017 A JP2016511017 A JP 2016511017A JP 2016511017 A JP2016511017 A JP 2016511017A JP 2016521277 A5 JP2016521277 A5 JP 2016521277A5
Authority
JP
Japan
Prior art keywords
alkyl
group
formula
bond
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016511017A
Other languages
English (en)
Japanese (ja)
Other versions
JP6353032B2 (ja
JP2016521277A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/058462 external-priority patent/WO2014177469A1/en
Publication of JP2016521277A publication Critical patent/JP2016521277A/ja
Publication of JP2016521277A5 publication Critical patent/JP2016521277A5/ja
Application granted granted Critical
Publication of JP6353032B2 publication Critical patent/JP6353032B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016511017A 2013-04-30 2014-04-25 ジアミノピラジン化合物、前記化合物を含有する医薬、その使用、およびその調製方法 Active JP6353032B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13165963 2013-04-30
EP13165963.3 2013-04-30
PCT/EP2014/058462 WO2014177469A1 (en) 2013-04-30 2014-04-25 Diaminopyrazine compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof

Publications (3)

Publication Number Publication Date
JP2016521277A JP2016521277A (ja) 2016-07-21
JP2016521277A5 true JP2016521277A5 (https=) 2017-08-24
JP6353032B2 JP6353032B2 (ja) 2018-07-04

Family

ID=48227015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016511017A Active JP6353032B2 (ja) 2013-04-30 2014-04-25 ジアミノピラジン化合物、前記化合物を含有する医薬、その使用、およびその調製方法

Country Status (4)

Country Link
US (1) US9018215B2 (https=)
EP (1) EP2991981B1 (https=)
JP (1) JP6353032B2 (https=)
WO (1) WO2014177469A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016126726A1 (en) 2015-02-02 2016-08-11 Forma Therapeutics, Inc. Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors
SG11201708622UA (en) 2015-02-02 2017-11-29 Forma Therapeutics Inc 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
EP3472131B1 (en) 2016-06-17 2020-02-19 Forma Therapeutics, Inc. 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors
GB201610854D0 (en) 2016-06-21 2016-08-03 Entpr Therapeutics Ltd Compounds
GB201619694D0 (en) 2016-11-22 2017-01-04 Entpr Therapeutics Ltd Compounds
GB201717051D0 (en) 2017-10-17 2017-11-29 Enterprise Therapeutics Ltd Compounds
GB201808093D0 (en) 2018-05-18 2018-07-04 Enterprise Therapeutics Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2432529T3 (es) * 2003-08-18 2013-12-04 Parion Sciences, Inc. Bloqueadores del canal de sodio de pirazinoilguanidina rematada
DE602008005140D1 (de) * 2007-05-07 2011-04-07 Novartis Ag Organische verbindungen
MX2010006421A (es) * 2007-12-10 2010-06-25 Novartis Ag Compuestos organicos.
US8859559B2 (en) * 2011-12-20 2014-10-14 Boehringer Ingelheim International Gmbh Substituted pyrazines and their use in the treatment of disease
EP2861577B1 (en) * 2012-05-25 2017-01-04 Boehringer Ingelheim International GmbH Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof

Similar Documents

Publication Publication Date Title
JP2016521277A5 (https=)
JP2014534222A5 (https=)
JP2013530179A5 (https=)
JP2016532677A5 (https=)
JP2013510125A5 (https=)
JP2015523383A5 (https=)
JP2013531029A5 (https=)
JP2016527220A5 (https=)
JP2016516699A5 (https=)
JP2016509594A5 (https=)
JP2015502379A5 (https=)
WO2016097869A4 (en) Fused ring heteroaryl compounds and their use as trk inhibitors
TWI455939B (zh) ｃＭＥＴ抑制劑
JP2008510828A5 (https=)
JP2013537203A5 (https=)
MX379276B (es) Pirazolo [3,4-b] piridin-6-carboxamidas n-sulfoniladas y metodo de uso.
NZ601847A (en) 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor
JP2011037841A5 (https=)
JP2014530801A5 (https=)
WO2010089510A3 (fr) Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique
JP2019528307A5 (https=)
JP2009532417A5 (https=)
JP2015526453A5 (https=)
JP2012054542A5 (ja) トリアゾール誘導体および複素環化合物
JP2016526563A5 (https=)